窥得儿医药 QDEL 深 沪
等待开盘 04-01 09:30:00 美东时间
16.43
+1.170
+7.67%
华盛通- 最 高16.61
- 今 开15.73
- 成交量 210.10万股
- 最 低 15.555
- 昨 收 15.26
- 总市值 11.19亿
- 52周最高 38.99
- 市盈率 静 --
- 换手率 3.09%
- 52周最低 14.45
- 委 比 -85.16%
- 总股本 6808.18万
- 历史最高 306.724
- 量 比 1.04
- 振 幅 6.91%
- 历史最低 12.35
- 每 手 1
- 风险率 4.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
SAN DIEGO, March 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, is pleased to announce the appoint...
03-24 19:00
Faster Cardiac Answers with High‑Sensitivity Troponin
SAN DIEGO, Feb. 19, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 56 of its Science Bytes podcast, featuring Dr. ...
02-19 22:17
电话会总结 ｜ QuidelOrtho(QDEL)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据QuidelOrtho业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 实验室业务（Labs）：Q4增长7%，全年增长6% - 即时检测业务（Point of Care）：Q4增长7%，其中分诊业务增长16%，免疫血液学业务增长3% - 区域表现：拉美地区增长18%，欧洲中东非洲地区增长4%，日本亚太地区增长6% **盈利能力：** - 调整后稀释每股收益：Q4为0.46美元，全年为2.12美元 - 毛利率：全年上升40个基点，但Q4同比下降，主要受关税和产品组合影响 - 调整后EBITDA：2025年实现130
02-12 12:29
财报速睇 | 窥得儿医药 2025财年Q4营收7.24亿美元，同比增长2.3%；归母净利润亏损1.31亿美元，同比亏损缩窄26.4%
华盛资讯2月12日讯，窥得儿医药公布2025财年Q4业绩，公司Q4营收7.24亿美元，同比增长2.3%，归母净利润亏损1.31亿美元，同比亏损缩窄26.4%。
02-12 07:45
QuidelOrtho shares are trading lower after the company reported Q4 financial results and issued FY26 adjusted EPS guidance below estimates.
QuidelOrtho shares are trading lower after the company reported Q4 financial re...
02-12 05:30
Earnings Summary: QuidelOrtho Q4
QuidelOrtho (NASDAQ:QDEL) reported its Q4 earnings results on Wednesday, Februa...
02-12 05:20
QuidelOrtho Sees FY2026 Adj EPS $2.00-$2.42 vs $2.51 Est; Sees Sales $2.700B-$2.900B vs $2.769B Est
QuidelOrtho (NASDAQ:QDEL) is looking for FY2026 Adj EPS of $2.00-$2.42 vs $2.51 analyst estimate. sees sales of $2.700 billion-$2.900 billion vs $2.769 billion analyst estimate.
02-12 05:10
QuidelOrtho Q4 Adj. EPS $0.46 Beats $0.42 Estimate, Sales $723.600M Beat $708.426M Estimate
QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.42 by 9 percent. This is a 26.98 percent decrease over earnings of $0.63 per share from the same
02-12 05:09
Earnings Scheduled For February 11, 2026
Companies Reporting Before The Bell • SiteOne Landscape Supply (NYSE:SITE) is p...
02-11 19:11
美股周涨跌榜 | Corvus制药周内狂飙211.8%，特应性皮炎新药临床试验结果积极；Avino银及金矿周涨超32.8%
Corvus制药周内狂飙211.8%，特应性皮炎新药临床试验结果积极；Avino银及金矿周涨超32.8%，现货白银站上100美元>>
01-24 09:50
